TWD 18.95
(-4.53%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 257.03 Million TWD | -2.39% |
2022 | 263.33 Million TWD | -71.61% |
2021 | 927.48 Million TWD | -0.86% |
2020 | 935.5 Million TWD | 83.9% |
2019 | 508.7 Million TWD | -36.26% |
2018 | 798.1 Million TWD | -6.64% |
2017 | 854.87 Million TWD | 47.73% |
2016 | 578.65 Million TWD | -14.42% |
2015 | 676.18 Million TWD | -23.06% |
2014 | 878.88 Million TWD | 351.17% |
2013 | 194.8 Million TWD | -67.6% |
2012 | 601.24 Million TWD | 106.47% |
2011 | 291.2 Million TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 266.48 Million TWD | 0.0% |
2024 Q2 | 265.04 Million TWD | 0.0% |
2023 Q3 | 256.33 Million TWD | -1.17% |
2023 Q1 | 260.49 Million TWD | -1.08% |
2023 Q2 | 259.36 Million TWD | -0.43% |
2023 FY | 257.03 Million TWD | -2.39% |
2023 Q4 | 257.03 Million TWD | 0.27% |
2022 Q2 | 421.17 Million TWD | -55.62% |
2022 Q3 | 263.82 Million TWD | -37.36% |
2022 Q4 | 263.33 Million TWD | -0.19% |
2022 Q1 | 948.92 Million TWD | 2.31% |
2022 FY | 263.33 Million TWD | -71.61% |
2021 Q3 | 928.98 Million TWD | -0.14% |
2021 Q1 | 931.85 Million TWD | -0.39% |
2021 Q2 | 930.27 Million TWD | -0.17% |
2021 FY | 927.48 Million TWD | -0.86% |
2021 Q4 | 927.48 Million TWD | -0.16% |
2020 Q1 | 494.54 Million TWD | -2.78% |
2020 Q2 | 1.16 Billion TWD | 136.0% |
2020 Q3 | 990.95 Million TWD | -15.09% |
2020 FY | 935.5 Million TWD | 83.9% |
2020 Q4 | 935.5 Million TWD | -5.6% |
2019 Q2 | 536.79 Million TWD | -55.69% |
2019 Q4 | 508.7 Million TWD | -2.69% |
2019 FY | 508.7 Million TWD | -36.26% |
2019 Q1 | 1.21 Billion TWD | 51.8% |
2019 Q3 | 522.75 Million TWD | -2.61% |
2018 Q1 | 898.5 Million TWD | 5.1% |
2018 FY | 798.1 Million TWD | -6.64% |
2018 Q4 | 798.1 Million TWD | -2.16% |
2018 Q3 | 815.74 Million TWD | -2.58% |
2018 Q2 | 837.36 Million TWD | -6.8% |
2017 Q3 | 1 Billion TWD | -25.44% |
2017 FY | 854.87 Million TWD | 47.73% |
2017 Q4 | 854.87 Million TWD | -15.05% |
2017 Q1 | 891.35 Million TWD | 54.04% |
2017 Q2 | 1.34 Billion TWD | 51.42% |
2016 Q4 | 578.65 Million TWD | 16.23% |
2016 Q3 | 497.83 Million TWD | 132.2% |
2016 Q2 | 214.4 Million TWD | -67.03% |
2016 Q1 | 650.33 Million TWD | -3.82% |
2016 FY | 578.65 Million TWD | -14.42% |
2015 Q3 | 701.69 Million TWD | -1.08% |
2015 Q4 | 676.18 Million TWD | -3.64% |
2015 Q2 | 709.37 Million TWD | -20.69% |
2015 FY | 676.18 Million TWD | -23.06% |
2015 Q1 | 894.47 Million TWD | 1.77% |
2014 Q3 | 794.7 Million TWD | 16.16% |
2014 Q1 | - TWD | -100.0% |
2014 Q2 | 684.12 Million TWD | 0.0% |
2014 FY | 878.88 Million TWD | 351.17% |
2014 Q4 | 878.88 Million TWD | 10.59% |
2013 Q4 | 194.8 Million TWD | 0.0% |
2013 FY | 194.8 Million TWD | -67.6% |
2013 Q1 | 626.85 Million TWD | 4.26% |
2013 Q2 | 626.85 Million TWD | 0.0% |
2012 Q2 | 556.76 Million TWD | 0.0% |
2012 FY | 601.24 Million TWD | 106.47% |
2012 Q4 | 601.24 Million TWD | 0.0% |
2012 Q3 | 601.24 Million TWD | 7.99% |
2011 Q4 | 291.2 Million TWD | 0.0% |
2011 FY | 291.2 Million TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Great Novel Therapeutics Biotech & Medicals | 10.88 Million TWD | -2262.274% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 366 Million TWD | 29.772% |
Visgeneer Inc. | 114.17 Million TWD | -125.131% |
Genomics BioSci & Tech. Co.,Ltd. | 222.24 Million TWD | -15.656% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
Sagittarius Life Science Corp | 6.25 Million TWD | -4009.994% |
NaviFUS Corp. | 25.83 Million TWD | -894.848% |
BioGend Therapeutics Co., Ltd. | 9.44 Million TWD | -2622.582% |
Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
TaiRx, Inc. | 8.96 Million TWD | -2765.86% |
Andros Pharmaceuticals Co.,Ltd | 22.02 Million TWD | -1067.086% |
Lin BioScience, Inc. | 29.02 Million TWD | -785.547% |
TaiwanJ Pharmaceuticals Co., Ltd. | 472 Thousand TWD | -54357.415% |
Lumosa Therapeutics Co., Ltd. | 8.11 Million TWD | -3066.675% |
Anti-Microbial Savior BioteQ Co., Ltd | - TWD | -Infinity% |
BioLASCO Taiwan Co., Ltd. | 51.43 Million TWD | -399.755% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 60.65 Million TWD | -323.793% |
Sunmax Biotechnology Co., Ltd. | 144.77 Million TWD | -77.544% |
RBC Bioscience Corporation | 412.59 Million TWD | 37.702% |
Bio Preventive Medicine Corp. | 106.2 Million TWD | -142.033% |
Syngen Biotech Co.,Ltd. | 386.07 Million TWD | 33.423% |
G&E Herbal Biotechnology Co., Ltd. | 1.29 Million TWD | -19763.91% |
AP Biosciences Inc | 70.42 Million TWD | -264.972% |
EirGenix Inc. | 436.54 Million TWD | 41.12% |
Enimmune corporation | 1.75 Million TWD | -14512.791% |
Lukas Biomedical Inc. | 69.9 Million TWD | -267.698% |
GlycoNex Incorporation | - TWD | -Infinity% |
BRIM Biotechnology, Inc. | 108 Thousand TWD | -237899.074% |
Level Biotechnology Inc. | 9.88 Million TWD | -2500.293% |
Pharmosa Biopharm Inc. | 118.41 Million TWD | -117.066% |
TaiMed Biologics Inc. | 521.7 Million TWD | 50.731% |
Mycenax Biotech Inc. | 569.78 Million TWD | 54.889% |
SynCore Biotechnology Co.,Ltd | - TWD | -Infinity% |
Eusol Biotech Co.,Ltd. | 1.6 Million TWD | -15904.919% |
Taiwan Advance Bio-Pharmaceutical Inc. | 86.89 Million TWD | -195.821% |
Feng Chi Biotech Corp. | 8.14 Million TWD | -3054.24% |
NeoCore Technology Co., Ltd. | 33.65 Million TWD | -663.815% |
TWi Biotechnology, Inc. | 5.6 Million TWD | -4487.525% |
Neith Corporation | 714 Thousand TWD | -35899.86% |
Sunny Pharmtech Inc. | 376.29 Million TWD | 31.692% |
VBI | - TWD | -Infinity% |
BiOptic Inc. | 85.79 Million TWD | -199.607% |
Ever Supreme Bio Technology Co., Ltd | 503 Thousand TWD | -51001.193% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Greenyn Biotechnology Co., Ltd | 55.91 Million TWD | -359.68% |
GeneReach Biotechnology Corp. | 97.74 Million TWD | -162.977% |
CHO Pharma, Inc. | - TWD | -Infinity% |
Medigen Biotechnology Corp. | 449.09 Million TWD | 42.766% |
3D Global Biotech Inc. | 4.08 Million TWD | -6196.889% |
Senhwa Biosciences, Inc. | 3.28 Million TWD | -7719.866% |
Intech Biopharm Corporation | 970.4 Million TWD | 73.512% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 35.409% |
TCI GENE Inc. | - TWD | -Infinity% |
MegaPro Biomedical Co., Ltd | 5.62 Million TWD | -4467.146% |
Taiwan Bio Therapeutics Co., Ltd | 250.51 Million TWD | -2.605% |
NatureWise Biotech & Medicals Corporation | 3.26 Million TWD | -7772.557% |
PharmaEngine, Inc. | 7.14 Million TWD | -3498.474% |
TaiGen Biopharmaceuticals Holdings Limited | 58.71 Million TWD | -337.811% |
OBI Pharma, Inc. | 439.88 Million TWD | 41.567% |
Meribank Biotech Co., Ltd | 14.81 Million TWD | -1635.46% |
Medigen Vaccine Biologics Corporation | 254.35 Million TWD | -1.055% |
Acepodia, Inc. | 233.45 Million TWD | -10.105% |
Caliway Biopharmaceuticals Co., Ltd. | 11.87 Million TWD | -2064.721% |